More effective access. Less time and trauma. Better treatment: The Erriva Extraforaminal Lumbar Interbody Fusion. Founded in 1990, coLigne AG Zurich, headquarter Zurich, Switzerland, develops and manufactures novel and practical spinal technologies including biomaterials.
Zurich, Switzerland, May 20th 2008 -- Coligne AG, a leading innovator in the design and manufacture of spinal implants, presents clinical follow up results of its unique Erriva ELIF treatment of the lumbar spine at this year’s Spineweek, Eurospine in Geneva, May 24th - May 31st 2008. The Erriva ELIF product line made of the proprietary biomaterial Ostapek, a high density long fiber carbon composite, is designed for lateral decompression, pedicle fixation and Ostapek interbody fusions. Erriva ELIF lumbar spine technology enables surgeons to reach the posterior elements, the interbody space and perform a complete spinal surgery that preserves more structures, minimizes blood loss and reduces muscle trauma
Lumbar Interbody Fusion is the classical treatment for disc disease or lumbar instability and could be performed by posterior (PLIF), anterior (ALIF) or transforaminal (TLIF) approach.
“For many years, the spine surgery community has been asking us to provide technology that equips them to be more complete in their treatment, while preserving vital anatomic structures and minimizing needed instrumentation, explains Robert Lange, CEO, Coligne AG.
“The Erriva achieves this by combining a novel surgical approach, Ostapek composite cages and pedicle fixation technology with unique instruments designed for this new procedure.
Based on the unilateral, extraforaminal technique first articulated by Dr. Recoules-Arche, Hopital Jaques Monod, Le Havre, France, the Erriva ELIF technique and instrumentation with its specially designed cages and pedicle fixation was developed.
A minimally invasive procedure: the Erriva ELIF technique
“Where required, Coligne Erriva ELIF technology allows the surgeon to employ a unilateral approach and work in healthy tissue, leaving most structures in place”, says co-developer Dr. Didier Recoules-Arche.
“Erriva ELIF treatment technology is a reliable surgical option in treatment of post-discectomy disc disease, which respects structures such as muscles, ligaments and bones, while diminishing the potential for neural and vascular trauma”, said Dr. Recoules. “It has been demonstrated to be effective at all operated lumbar levels including L5-S1.”
Encouraging clinical results
In 73 of 75 cases fusion was achieved with no destabilization. Minimal blood loss (Press Release Distribution By PressReleasePoint
Contact:
coLigne AG
Felix Kraeft
Tel.: 0041 43 343 8002
Fax: 0041 43 343 8009
felix.kraeft@coligne.com
Utoquai 43
CH – 8008 Zurich
Switzerland
Dr. Dietmar Schaffarczyk
coLigne AG
Utoqai 43
CH – 8008 Zurich
Switzerland
Tel.: 0041 43 343 8000
Fax: 0041 43 343 8009
dietmar.schaffarczyk@coligne.com
http://www.coligne.com
|
Share: